Form 4: Hims & Hers Health PAO Exercises and Sells Shares Under 10b5-1 Plan

Irene Becklund, PAO of Hims & Hers Health, executed stock option exercises and sales of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Summary

• Irene Becklund, the PAO of Hims & Hers Health, Inc., reported transactions involving Class A Common Stock.
• On July 16, 2024, Becklund exercised stock options to acquire 472 shares at a price of $9.41 per share.
• Simultaneously, Becklund sold 472 shares of Class A Common Stock at $23.23 per share.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on September 11, 2023.
• Following these transactions, Becklund directly owns 2,913 shares of Class A Common Stock and 2,359 stock options.
• The stock options vest in equal monthly installments beginning February 16, 2021, contingent upon continuous service with the issuer.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are part of a pre-planned trading strategy, mitigating concerns about insider sentiment. The exercise of options is a positive sign, but the sale tempers the overall outlook.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, indicating a planned and transparent approach to stock transactions.
• The exercise of stock options demonstrates confidence in the company's future prospects, as the reporting person chose to acquire shares at the exercise price.

Negatives

• The sale of shares, even under a 10b5-1 plan, could be perceived negatively by some investors if they interpret it as a lack of confidence in the company's future performance.

Risks

• While the 10b5-1 plan provides a defense against insider trading allegations, the market may still react negatively to insider sales.
• Continued sales by insiders could create downward pressure on the stock price.

Future Outlook

The document does not contain specific forward-looking statements, but the ongoing vesting of stock options suggests continued alignment of the reporting person's interests with the company's performance.

Industry Context

Insider transactions are common in publicly traded companies, and the use of 10b5-1 plans is a standard practice to avoid insider trading concerns. Investors often monitor these filings for insights into management's sentiment and potential future stock performance.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, including those in the telehealth sector like Teladoc Health and Amwell.
• The vesting schedule of the stock options, with monthly installments, is also a typical arrangement for employee equity compensation.
• The size of the transaction, involving 472 shares, is relatively small compared to transactions by larger shareholders or executives at more established companies.

Stakeholder Impact

• Shareholders may react to the insider selling, although the 10b5-1 plan should mitigate concerns.
• Employees may view the transaction as a standard part of executive compensation.

Key Dates